Fred Hite - Orthopediatrics Corp CFO, Director
| KIDS Stock | USD 25.91 0.52 2.05% |
Director
Mr. Fred L. Hite is Chief Financial Officer, Director of the Company. He has served as our Chief Financial Officer since February 2015 and as a director since August 2015. Prior to joining our company, from 2004 through 2014, Mr. Hite served as the Chief Financial Officer and Investor Relations Officer of Symmetry Medical Inc., or Symmetry, a company previously listed on the New York Stock Exchange. Prior to joining Symmetry, Mr. Hite spent 13 years with General Electric Corporation in a variety of financial positions and areas including commercial, manufacturing, sourcing and services since 2015.
| Age | 56 |
| Tenure | 9 years |
| Address | 2850 Frontier Drive, Warsaw, IN, United States, 46582 |
| Phone | 574 268 6379 |
| Web | https://www.orthopediatrics.com |
Orthopediatrics Corp Management Efficiency
The company has return on total asset (ROA) of (0.0394) % which means that it has lost $0.0394 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0763) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. At this time, Orthopediatrics Corp's Asset Turnover is comparatively stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| David Bronson | CONMED | 67 | |
| Aimee Weisner | Glaukos Corp | 51 | |
| Martha Aronson | CONMED | 53 | |
| David Hoffmeister | Glaukos Corp | 66 | |
| Charles Farkas | CONMED | 68 | |
| Gilbert Kliman | Glaukos Corp | 61 | |
| Joel Suiter | SurModics | N/A | |
| Jerome Lande | CONMED | 45 | |
| Marc Stapley | Glaukos Corp | 50 | |
| Kristina Wright | Paragon 28 | 47 | |
| John Workman | CONMED | 69 | |
| Saqib Iqbal | Si Bone | N/A | |
| Stephanie Zhadkevich | iRhythm Technologies | N/A | |
| Mark Foley | Glaukos Corp | 55 | |
| Brian Concannon | CONMED | 62 | |
Management Performance
| Return On Equity | -0.0763 | ||||
| Return On Asset | -0.0394 |
Orthopediatrics Corp Leadership Team
Elected by the shareholders, the Orthopediatrics Corp's board of directors comprises two types of representatives: Orthopediatrics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthopediatrics. The board's role is to monitor Orthopediatrics Corp's management team and ensure that shareholders' interests are well served. Orthopediatrics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthopediatrics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel JD, General Legal | ||
| MBAMSHA CHE, President Technologies | ||
| Daniel Gerritzen, General Counsel and Vice President of Legal and Human Resources | ||
| Joel Batts, Senior Affairs | ||
| David Bailey, Executive Vice President | ||
| Mark Throdahl, President CEO, Director | ||
| Fred Hite, CFO, Director | ||
| Joseph Hauser, President Correction | ||
| Gregory Odle, Executive Vice President | ||
| Mark Karshner, Senior Sales |
Orthopediatrics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthopediatrics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0763 | ||||
| Return On Asset | -0.0394 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 624.04 M | ||||
| Shares Outstanding | 24.22 M | ||||
| Shares Owned By Insiders | 32.52 % | ||||
| Shares Owned By Institutions | 70.85 % | ||||
| Number Of Shares Shorted | 801.13 K | ||||
| Price To Earning | (10.06) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orthopediatrics Stock Analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.